- Home
- ARWR vs BHC Comparison
ARWR vs BHC Comparison
Compare ARWR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- BHC
- Stock Information
- Founded
- ARWR 2003
- BHC N/A
- Country
- ARWR United States
- BHC Canada
- Employees
- ARWR N/A
- BHC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ARWR Health Care
- BHC Health Care
- Exchange
- ARWR Nasdaq
- BHC Nasdaq
- Market Cap
- ARWR 1.8B
- BHC 1.7B
- IPO Year
- ARWR 1993
- BHC N/A
- Fundamental
- Price
- ARWR $16.07
- BHC $4.53
- Analyst Decision
- ARWR Buy
- BHC Hold
- Analyst Count
- ARWR 10
- BHC 5
- Target Price
- ARWR $42.13
- BHC $7.20
- AVG Volume (30 Days)
- ARWR 1.9M
- BHC 1.5M
- Earning Date
- ARWR 05-12-2025
- BHC 04-30-2025
- Dividend Yield
- ARWR N/A
- BHC N/A
- EPS Growth
- ARWR N/A
- BHC N/A
- EPS
- ARWR N/A
- BHC N/A
- Revenue
- ARWR $545,209,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- ARWR $4,380.43
- BHC $3.71
- Revenue Next Year
- ARWR $66.56
- BHC $5.03
- P/E Ratio
- ARWR N/A
- BHC N/A
- Revenue Growth
- ARWR 1436.97
- BHC 8.53
- 52 Week Low
- ARWR $9.57
- BHC $3.96
- 52 Week High
- ARWR $30.41
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ARWR 59.58
- BHC 39.91
- Support Level
- ARWR $14.92
- BHC $4.50
- Resistance Level
- ARWR $17.19
- BHC $4.61
- Average True Range (ATR)
- ARWR 0.95
- BHC 0.13
- MACD
- ARWR 0.11
- BHC 0.03
- Stochastic Oscillator
- ARWR 70.29
- BHC 21.30
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.